CRISPR and genome editing: understanding the gene editing technology and its limitations

and genome

Explore CRISPR

Decoding the mechanism, advancements, and ethical cosniderations of CRISPR technology.

The discovery of CRISPR-Cas9 technology in genetic research marks a monumental leap forward. This system is adapted from a genome editing mechanism in bacteria. It acts as a pair of molecular scissors. They allow scientists to modify an organism’s DNA with great precision.

Gene editing tools have developed incrementally. But, CRISPR technology has sped up the pace. It has changed theory into practice. This tool has many benefits. Many scientists expect CRISPR to bring big breakthroughs. Also, the global CRISPR genome editing market is projected to exceed $30 billion by 2033 (see Fig.1).

Projected CRISPR and Cas gene market wordlwide

Figure 1. Projected CRISPR and Cas gene market wordlwide

Yet, as with new advancements, some limitations and concerns must be addressed. As Ian Wilmut, the leader of the research group that, in 1996, first cloned a mammal from an adult somatic cell, a Finnish Dorset lamb named Dolly, put it: “I see nothing wrong ethically with correcting single gene defects [through genetic engineering]. But I am concerned about any other kind of intervention, for anything else would be an experiment, [which would] impose our will on future generations [and take unreasonable chances] with their welfare … [Thus] such intervention is beyond the scope of consideration.”

In this piece, we will put on a skeptical lens and explore whether CRISPR is the technology that will do more good or harm. Such an evaluation can be done by weighing the innovation’s benefits versus its imitations. Without further ado, let’s start our investigation.

In-depth understanding the CRISPR-Cas9 system

Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR) technology is a groundbreaking tool in molecular biology. It lets scientists edit genomes very precisely, efficiently, and flexibly.

CRISPR sequences are specific sections of a bacterium’s genome that serve as a type of immune memory. When a bacterium manages to survive an attack by a virus, it takes a piece of the invader’s DNA and stores it in its own genome. This creates a “wanted gallery” of sorts, which the bacterial defense system can use to recognize and defend against the virus in future encounters.

Role of Cas9 nuclease in genome engineering

The Cas9 enzyme, with the guidance of a custom-designed RNA molecule, can locate a matching genomic sequence in a target organism and precisely cut the DNA at that location. This technique enables the removal or addition of genetic material in the organism.

In 2012, scientists Jennifer Doudna and Emmanuelle Charpentier played a crucial role in adapting this system for use in other organisms. This breakthrough has been widely recognized as one of the most significant advancements in biotechnology in recent times.

The process of identifying and cutting target genes

Scientists have developed a brief sequence of RNA that matches the particular gene they intend to modify. Combined with the Cas9 protein, this RNA guide forms a complex that can locate the target DNA sequence and cause a break at a specific site. The cell’s inherent repair mechanism then takes over and can be utilized to introduce modifications or corrections to the gene.

The CRISPR-Cas9 system is a revolutionary advance in genetic engineering. It enables highly precise edits that are reshaping biotechnology. This tool allows for efficient and flexible genome editing. It also shows the potential of genetic changes in advancing medical science and treatments.

The mechanism of gene editing using CRISPR

CRISPR-Cas9 has revolutionized gene editing by simplifying the process to a straightforward RNA programming step.

  • CRISPR RNA-guided gene targeting. The targeting efficiency of the RNA guide is a critical aspect of the CRISPR system. A study published in the journal “Nature” demonstrated that the targeting efficiency could be over 70%, depending on the nature of the guide RNA and the genomic context of the target sequence.
  • Editing efficiency and precision in gene modification. While CRISPR-Cas9 boasts a high success rate, the precision can be affected by the off-target effects, where the Cas9 enzyme cuts outside the intended region. Advances in CRISPR technology have introduced ‘high-fidelity’ versions of the Cas9 enzyme with reduced off-target activity, as reported in “Science.”

The CRISPR-Cas9 mechanism simplifies gene editing. It does this by using an efficient RNA-guided process. This process enhances targeting accuracy and minimizes off-target effects. It significantly improves the precision of genetic modifications.

Advancements in CRISPR technology

The advent of CRISPR has led to significant developments in gene editing.

Development of CRISPR-Cas9 genome editing technology

Researchers have been constantly improving CRISPR-Cas9 since its inception. They have discovered other Cas proteins like Cpf1, which have different advantages in genome editing. Cpf1 leaves sticky ends on DNA which are more useful for inserting new genes than the blunt ends created by Cas9.

Improvements in editing efficiency and specificity

Recent advancements in CRISPR technology have led to the development of ‘base editors.’ These specially designed proteins, when attached to a Cas protein, can change a single DNA base into another without cutting the DNA strand. This significantly reduces the chances of unwanted mutations. Through base editing, it is possible to rectify almost 60% of the known genetic disorders caused by point mutations.

The CRISPR-Cas9 system has revolutionized genetic research by providing an accessible and versatile tool for genome editing. This technology has democratized the field and spurred ongoing innovations to enhance its specificity and efficiency. As a result, it has paved the way for potential cures for genetic diseases.

CRISPR applications in medicine

CRISPR applications in medicine

CRISPR is very precise. It makes it a great tool in the fight against genetic disorders. And offers hope where traditional medicine has had little success. Here are some examples to consider:

1. Treating genetic diseases

CRISPR has played a significant role in the recent advancements in treating diseases such as cystic fibrosis and Duchenne muscular dystrophy. The technology can potentially cure genetic disorders by precisely correcting mutations in somatic cells.

A study in “Nature Medicine” reveals that trials have had promising outcomes in gene editing in the human body. This could lead to the reversal of inherited diseases.

2. Cancer treatment and therapy

Oncologists use CRISPR to modify immune cells. They do this to make the cells target and destroy cancer cells. For example, T-cells can be engineered to express CARs. CAR T-cell therapy uses these CARs to recognize and kill cancer cells. Trials detailed in “The New England Journal of Medicine” have shown that CRISPR can make cancer therapies more precise and less toxic.

3. Stem cell research

CRISPR has revolutionized stem cell research. It lets scientists create models of diseases in stem cells from patient’s tissues. They can then study the diseases in detail. The journal “Cell Stem Cell” reports that these models are crucial for understanding disease mechanisms and testing new treatments.

CRISPR is advancing quickly in medicine. It could revolutionize how we treat and maybe cure genetic diseases. This breakthrough has the potential to enable personalized and precise medicine. But, it is crucial to consider the ethics and safety of this technology.

Six key CRISPR limitations and ethical consideration

CRISPR technology is groundbreaking. Yet, its application is full of technical limits and deep ethical questions.

1. Inherent technical challenges

Issues with precision temper CRISPR’s promiseCRISPR’s. It is adept at targeting DNA. But, off-target mutations can occur. They can lead to unforeseen consequences. According to a study in “Nature Methods,” the frequency of off-target effects varies, but with careful design and testing, these can be minimized.

2. Genetic Mosaicism

Genetic mosaicism is a concern. The edit is present in some cells, but in others, it is not. This is especially worrying when editing embryonic or germline cells. This phenomenon, detailed in “Cell,” can lead to incomplete treatment of genetic conditions and complicate the predictability of outcomes in edited organisms.

3. Delivery mechanisms

Efficiently delivering CRISPR components into cells remains a challenge, and various methods have been explored, including viral vectors, liposomes, and nanoparticles. However, each of these methods has limitations regarding efficiency, cell-type specificity, and potential toxicity, as presented in “Advanced Drug Delivery Reviews.”

4. Reproducibility and consistency

There is a significant challenge in using CRISPR gene editing technology due to its varying efficiency. The success of an edit can be influenced by factors such as the cell cycle stage and the compactness of the DNA. The importance of standardized protocols to improve the consistency and reproducibility of results.

5. Immune responses

The immune system’s potential to recognize and attack CRISPR components, such as the Cas9 protein, poses another limitation. A paper in “Nature Medicine” points out that pre-existing immunity to Cas9 proteins derived from common bacteria could reduce the effectiveness of CRISPR-based therapies.

6. Ethical dilemmas

Beyond technical challenges, CRISPR faces ethical concerns, particularly regarding germline editing. Editing embryos to correct genetic diseases raises the specter of creating so-called ‘designer babies,’ where genetic enhancements could be selected for non-therapeutic reasons. World Health Organization (WHO) stresses the need for an international consensus on the ethical applications of this technology.

CRISPR’s potential is substantial, yet it is crucial to address its limitations and engage in ethical discourse to ensure this powerful tool is used responsibly and for the greater good of humanity.


CRISPR technology has emerged as a ray of hope in the pursuit to overcome genetic disorders, opening a new chapter in the history of medical science. Its capability to alter the human genome has sparked a vision of a future free from inherited diseases, with each new breakthrough adding to its potential.

However, genetic modification is a powerful tool that comes with ethical and technical challenges and profound societal implications. Therefore, we must approach it cautiously, ensuring precision and safety.

As we approach the beginning of a new era in genetics, CRISPR technology is being discussed in many different contexts. It is important to balance innovation with the responsibility of using the technology to improve society.

Contact Avenga to get additional insights on CRISPR and similar innovations.

Other articles


Book a meeting

Zoom 30 min

or call us+1 (800) 917-0207

Ready to innovate your business?

We are! Let’s kick-off our journey to success!